EEF2K anticorps
Aperçu rapide pour EEF2K anticorps (ABIN6989778)
Antigène
Voir toutes EEF2K AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain, Souris
-
Purification
- Purified by Protein A.
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 406-725 of human EEF2K (NP_037434.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
IF(ICC) 1:50-200
IF() -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- EEF2K (Eukaryotic Elongation Factor-2 Kinase (EEF2K))
-
Autre désignation
- EEF2K
-
Sujet
-
Synonyms: EEF2K,HSU93850,eEF-2K
Background: This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment.
-
ID gène
- 29904
-
UniProt
- O00418
-
Pathways
- AMPK Signaling
Antigène
-